TrialAnnals of oncology : official journal of the European Society for Medical Oncology2023

Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial.

K N Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.